Correction: Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis.
1/5 보강
[This corrects the article DOI: 10.3389/fimmu.2026.1738352.].
APA
Jia J, Zeng Y, et al. (2026). Correction: Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis.. Frontiers in immunology, 17, 1818306. https://doi.org/10.3389/fimmu.2026.1818306
MLA
Jia J, et al.. "Correction: Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis.." Frontiers in immunology, vol. 17, 2026, pp. 1818306.
PMID
41884847 ↗
Abstract 한글 요약
[This corrects the article DOI: 10.3389/fimmu.2026.1738352.].
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Stereotactic body radiotherapy plus lenvatinib and sintilimab with and without transarterial embolization for advanced hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, propensity score-matched retrospective analysis.
- Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis.
- Highly Expressed Fatty Acid-Binding Protein 6 Mediates Lipid Metabolism Remodeling in Tumor Cells via Intracellular Bile Acid Transport to Promote Pancreatic Cancer Metastasis.
- The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response.
📖 전문 본문 읽기 PMC JATS · ~1 KB · 영문
Incorrect PFS rates numerical values were reported.
A correction has been made to the section “Results, Survival outcomes, Paragraph 1”:
“The one-year PFS rate was 50.4% in RT group versus 16.6% in Non-RT group, while the two-year PFS rate was 23.8% versus 9.2%, respectively.”
Incorrect OS rates numerical values were reported.
A correction has been made to the section “Results, Survival outcomes, Paragraph 2”:
“The one-year and two-year OS rates were 80.4% and 50.9%, respectively, in RT group, compared to 62.2% and 34.1%, respectively, in Non-RT group.”
The PFS data after PSM was incorrectly copied as OS data.
A correction has been made to the section “Results, Survival outcomes, Paragraph 3”:
“After PSM, significant improvements in PFS (Figures 3C, 12.7 months vs 6.5 months, HR = 0.47, 95%CI:0.39-0.56, p<0.001)”
The original version of this article has been updated.
A correction has been made to the section “Results, Survival outcomes, Paragraph 1”:
“The one-year PFS rate was 50.4% in RT group versus 16.6% in Non-RT group, while the two-year PFS rate was 23.8% versus 9.2%, respectively.”
Incorrect OS rates numerical values were reported.
A correction has been made to the section “Results, Survival outcomes, Paragraph 2”:
“The one-year and two-year OS rates were 80.4% and 50.9%, respectively, in RT group, compared to 62.2% and 34.1%, respectively, in Non-RT group.”
The PFS data after PSM was incorrectly copied as OS data.
A correction has been made to the section “Results, Survival outcomes, Paragraph 3”:
“After PSM, significant improvements in PFS (Figures 3C, 12.7 months vs 6.5 months, HR = 0.47, 95%CI:0.39-0.56, p<0.001)”
The original version of this article has been updated.
출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II Study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Associations of electronic health literacy with related factors in individuals diagnosed with colorectal cancer: a cross-sectional analysis.
- Addition of Venetoclax to Azacitidine Did Not Improve Survival in Acute Myeloid Leukemia and Was Not Well Tolerated: Real World Experience.
- Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncology.
- Effectiveness of mindfulness-based stress reduction in managing fatigue, anxiety, and depression among non-small cell lung cancer patients receiving surgery and adjuvant chemotherapy: A randomized controlled trial.